Omega-3 Ingredients for Pharmaceuticals - Global and China Top Players Market Share and Ranking 2023

Publication Month: Mar 2023 | No. of Pages: 151 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Omega-3 Ingredients for Pharmaceuticals should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Omega-3 Ingredients for Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Omega-3 Ingredients for Pharmaceuticals market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Cardiovascular Diseases grew percent to account for percent of the total market sales, and Autoimmune Diseases grew percent.
Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega-3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.
This report studies and analyses global Omega-3 Ingredients for Pharmaceuticals status and future trends, helps the client to determine the Omega-3 Ingredients for Pharmaceuticals market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Omega-3 Ingredients for Pharmaceuticals, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Omega-3 Ingredients for Pharmaceuticals market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Omega-3 Ingredients for Pharmaceuticals sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Omega-3 Ingredients for Pharmaceuticals sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Omega-3 Ingredients for Pharmaceuticals key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Omega-3 Ingredients for Pharmaceuticals key producing regions, capacity, production, and year over year growth
(6) Omega-3 Ingredients for Pharmaceuticals industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Avestia Pharma
Novasep
AbbVie Inc
KD Pharma Group
BASF SE
Corbion
DSM
AstraZeneca
GSK plc
Fresenius Kabi AG
Croda International Plc
AMARIN CORPORATION
ANI Pharmaceuticals, Inc
Epax
Strides Pharma Science Limited
Pharma Marine AS
KinOmega Biopharm Inc
Camber Pharmaceuticals, Inc
Market segment by Type, covers
Docosahexaenoic Acid
Eicosapentaenoic Acid
Alpha-Linolenic Acid
Market segment by Application, can be divided into
Cardiovascular Diseases
Autoimmune Diseases
Bone & Joint Disorders
Neurological Disorders
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Omega-3 Ingredients for Pharmaceuticals product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Omega-3 Ingredients for Pharmaceuticals market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Omega-3 Ingredients for Pharmaceuticals market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Omega-3 Ingredients for Pharmaceuticals, percent & CAGR, 2018-2029
Chapter 5: Omega-3 Ingredients for Pharmaceuticals industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions

1 Market Overview
1.1 Omega-3 Ingredients for Pharmaceuticals Definition
1.2 Global Omega-3 Ingredients for Pharmaceuticals Market Size and Forecast
1.2.1 By Consumption Value, Global Omega-3 Ingredients for Pharmaceuticals Market Size,2018-2029
1.2.2 By Sales Quantity, Global Omega-3 Ingredients for Pharmaceuticals Market Size,2018-2029
1.2.3 Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP),2018-2029
1.3 China Omega-3 Ingredients for Pharmaceuticals Market Size and Forecast
1.3.1 By Consumption Value, China Omega-3 Ingredients for Pharmaceuticals Market Size,2018-2029
1.3.2 By Sales Quantity, China Omega-3 Ingredients for Pharmaceuticals Market Size,2018-2029
1.3.3 China Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), 2018-2029
1.4 Share of China Omega-3 Ingredients for Pharmaceuticals Market with Respect to the Global Market
1.4.1 By Consumption Value, China Omega-3 Ingredients for Pharmaceuticals Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Omega-3 Ingredients for Pharmaceuticals Market Share in Global, 2018-2029
1.4.3 Omega-3 Ingredients for Pharmaceuticals Market Size: China VS Global, 2018-2029
1.5 Omega-3 Ingredients for Pharmaceuticals Market Dynamics
1.5.1 Omega-3 Ingredients for Pharmaceuticals Market Drivers
1.5.2 Omega-3 Ingredients for Pharmaceuticals Market Restraints
1.5.3 Omega-3 Ingredients for Pharmaceuticals Industry Trends
1.5.4 Omega-3 Ingredients for Pharmaceuticals Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Omega-3 Ingredients for Pharmaceuticals, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Omega-3 Ingredients for Pharmaceuticals, Global Market Share by Company, 2018-2023
2.3 Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Omega-3 Ingredients for Pharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Omega-3 Ingredients for Pharmaceuticals Concentration Ratio
2.6 Global Omega-3 Ingredients for Pharmaceuticals Mergers & Acquisitions, Expansion Plans
2.7 Global Omega-3 Ingredients for Pharmaceuticals Manufacturers Product Type
2.8 Head Office and Omega-3 Ingredients for Pharmaceuticals Production Site of Key Manufacturer
2.9 Omega-3 Ingredients for Pharmaceuticals Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Omega-3 Ingredients for Pharmaceuticals, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Omega-3 Ingredients for Pharmaceuticals, China Market Share by Company, 2018-2023
3.3 China Omega-3 Ingredients for Pharmaceuticals Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Omega-3 Ingredients for Pharmaceuticals Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Omega-3 Ingredients for Pharmaceuticals Capacity by Region
4.3 Global Omega-3 Ingredients for Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Omega-3 Ingredients for Pharmaceuticals Production by Region, 2018-2029
4.5 Global Omega-3 Ingredients for Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Omega-3 Ingredients for Pharmaceuticals Industry Chain
5.2 Omega-3 Ingredients for Pharmaceuticals Upstream Analysis
5.2.1 Omega-3 Ingredients for Pharmaceuticals Core Raw Materials
5.2.2 Main Manufacturers of Omega-3 Ingredients for Pharmaceuticals Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Omega-3 Ingredients for Pharmaceuticals Production Mode
5.6 Omega-3 Ingredients for Pharmaceuticals Procurement Model
5.7 Omega-3 Ingredients for Pharmaceuticals Industry Sales Model and Sales Channels
5.7.1 Omega-3 Ingredients for Pharmaceuticals Sales Model
5.7.2 Omega-3 Ingredients for Pharmaceuticals Typical Distributors
6 Sights by Type
6.1 Omega-3 Ingredients for Pharmaceuticals Classification
6.1.1 Docosahexaenoic Acid
6.1.2 Eicosapentaenoic Acid
6.1.3 Alpha-Linolenic Acid
6.2 By Type, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029
6.4 By Type, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029
6.5 By Type, Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Omega-3 Ingredients for Pharmaceuticals Segment by Application
7.1.1 Cardiovascular Diseases
7.1.2 Autoimmune Diseases
7.1.3 Bone & Joint Disorders
7.1.4 Neurological Disorders
7.1.5 Other
7.2 By Application, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029
7.4 By Application, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029
7.5 By Application, Global Omega-3 Ingredients for Pharmaceuticals Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029
8.3 By Region, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Omega-3 Ingredients for Pharmaceuticals & Forecasts, 2018-2029
8.4.2 By Country, North America Omega-3 Ingredients for Pharmaceuticals Market Size Market Share
8.5 Europe
8.5.1 Europe Omega-3 Ingredients for Pharmaceuticals Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Omega-3 Ingredients for Pharmaceuticals Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Omega-3 Ingredients for Pharmaceuticals Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Omega-3 Ingredients for Pharmaceuticals Market Size Market Share
8.7 South America
8.7.1 South America Omega-3 Ingredients for Pharmaceuticals Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Omega-3 Ingredients for Pharmaceuticals Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Omega-3 Ingredients for Pharmaceuticals Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029
9.3 By Country, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.4.2 By Type, U.S. Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.5.2 By Type, Europe Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.6.2 By Type, China Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.7.2 By Type, Japan Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.8.2 By Type, South Korea Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.10.2 By Type, India Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Avestia Pharma
10.1.1 Avestia Pharma Company Information, Head Office, Market Area, and Industry Position
10.1.2 Avestia Pharma Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.1.3 Avestia Pharma Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Avestia Pharma Company Profile and Main Business
10.1.5 Avestia Pharma Recent Developments
10.2 Novasep
10.2.1 Novasep Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novasep Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.2.3 Novasep Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novasep Company Profile and Main Business
10.2.5 Novasep Recent Developments
10.3 AbbVie Inc
10.3.1 AbbVie Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 AbbVie Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.3.3 AbbVie Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 AbbVie Inc Company Profile and Main Business
10.3.5 AbbVie Inc Recent Developments
10.4 KD Pharma Group
10.4.1 KD Pharma Group Company Information, Head Office, Market Area, and Industry Position
10.4.2 KD Pharma Group Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.4.3 KD Pharma Group Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 KD Pharma Group Company Profile and Main Business
10.4.5 KD Pharma Group Recent Developments
10.5 BASF SE
10.5.1 BASF SE Company Information, Head Office, Market Area, and Industry Position
10.5.2 BASF SE Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.5.3 BASF SE Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 BASF SE Company Profile and Main Business
10.5.5 BASF SE Recent Developments
10.6 Corbion
10.6.1 Corbion Company Information, Head Office, Market Area, and Industry Position
10.6.2 Corbion Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.6.3 Corbion Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Corbion Company Profile and Main Business
10.6.5 Corbion Recent Developments
10.7 DSM
10.7.1 DSM Company Information, Head Office, Market Area, and Industry Position
10.7.2 DSM Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.7.3 DSM Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 DSM Company Profile and Main Business
10.7.5 DSM Recent Developments
10.8 AstraZeneca
10.8.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.8.2 AstraZeneca Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.8.3 AstraZeneca Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 AstraZeneca Company Profile and Main Business
10.8.5 AstraZeneca Recent Developments
10.9 GSK plc
10.9.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.9.2 GSK plc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.9.3 GSK plc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK plc Company Profile and Main Business
10.9.5 GSK plc Recent Developments
10.10 Fresenius Kabi AG
10.10.1 Fresenius Kabi AG Company Information, Head Office, Market Area, and Industry Position
10.10.2 Fresenius Kabi AG Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.10.3 Fresenius Kabi AG Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Fresenius Kabi AG Company Profile and Main Business
10.10.5 Fresenius Kabi AG Recent Developments
10.11 Croda International Plc
10.11.1 Croda International Plc Company Information, Head Office, Market Area, and Industry Position
10.11.2 Croda International Plc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.11.3 Croda International Plc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Croda International Plc Company Profile and Main Business
10.11.5 Croda International Plc Recent Developments
10.12 AMARIN CORPORATION
10.12.1 AMARIN CORPORATION Company Information, Head Office, Market Area, and Industry Position
10.12.2 AMARIN CORPORATION Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.12.3 AMARIN CORPORATION Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 AMARIN CORPORATION Company Profile and Main Business
10.12.5 AMARIN CORPORATION Recent Developments
10.13 ANI Pharmaceuticals, Inc
10.13.1 ANI Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
10.13.2 ANI Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.13.3 ANI Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 ANI Pharmaceuticals, Inc Company Profile and Main Business
10.13.5 ANI Pharmaceuticals, Inc Recent Developments
10.14 Epax
10.14.1 Epax Company Information, Head Office, Market Area, and Industry Position
10.14.2 Epax Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.14.3 Epax Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Epax Company Profile and Main Business
10.14.5 Epax Recent Developments
10.15 Strides Pharma Science Limited
10.15.1 Strides Pharma Science Limited Company Information, Head Office, Market Area, and Industry Position
10.15.2 Strides Pharma Science Limited Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.15.3 Strides Pharma Science Limited Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Strides Pharma Science Limited Company Profile and Main Business
10.15.5 Strides Pharma Science Limited Recent Developments
10.16 Pharma Marine AS
10.16.1 Pharma Marine AS Company Information, Head Office, Market Area, and Industry Position
10.16.2 Pharma Marine AS Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.16.3 Pharma Marine AS Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Pharma Marine AS Company Profile and Main Business
10.16.5 Pharma Marine AS Recent Developments
10.17 KinOmega Biopharm Inc
10.17.1 KinOmega Biopharm Inc Company Information, Head Office, Market Area, and Industry Position
10.17.2 KinOmega Biopharm Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.17.3 KinOmega Biopharm Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 KinOmega Biopharm Inc Company Profile and Main Business
10.17.5 KinOmega Biopharm Inc Recent Developments
10.18 Camber Pharmaceuticals, Inc
10.18.1 Camber Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
10.18.2 Camber Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
10.18.3 Camber Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Camber Pharmaceuticals, Inc Company Profile and Main Business
10.18.5 Camber Pharmaceuticals, Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

Tables and Figures

Table 1. Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Omega-3 Ingredients for Pharmaceuticals Market Restraints
Table 3. Omega-3 Ingredients for Pharmaceuticals Market Trends
Table 4. Omega-3 Ingredients for Pharmaceuticals Industry Policy
Table 5. Global Omega-3 Ingredients for Pharmaceuticals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Omega-3 Ingredients for Pharmaceuticals Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Omega-3 Ingredients for Pharmaceuticals Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Omega-3 Ingredients for Pharmaceuticals Mergers & Acquisitions, Expansion Plans
Table 12. Global Omega-3 Ingredients for Pharmaceuticals Manufacturers Product Type
Table 13. Head Office and Omega-3 Ingredients for Pharmaceuticals Production Site of Key Manufacturer
Table 14. Omega-3 Ingredients for Pharmaceuticals Capacity of Major Manufacturers and Future Plan
Table 15. China Omega-3 Ingredients for Pharmaceuticals Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Omega-3 Ingredients for Pharmaceuticals Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Omega-3 Ingredients for Pharmaceuticals Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Omega-3 Ingredients for Pharmaceuticals Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Omega-3 Ingredients for Pharmaceuticals Production by Region, 2018-2023, (K Units)
Table 20. Global Omega-3 Ingredients for Pharmaceuticals Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Omega-3 Ingredients for Pharmaceuticals Upstream (Raw Materials)
Table 22. Global Omega-3 Ingredients for Pharmaceuticals Typical Customers
Table 23. Omega-3 Ingredients for Pharmaceuticals Typical Distributors
Table 24. By Type, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2018-2029
Table 34. Avestia Pharma Company Information, Head Office, Market Area, and Industry Position
Table 35. Avestia Pharma Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 36. Avestia Pharma Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Avestia Pharma Company Profile and Main Business
Table 38. Avestia Pharma Recent Developments
Table 39. Novasep Company Information, Head Office, Market Area, and Industry Position
Table 40. Novasep Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 41. Novasep Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novasep Company Profile and Main Business
Table 43. Novasep Recent Developments
Table 44. AbbVie Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. AbbVie Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 46. AbbVie Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. AbbVie Inc Company Profile and Main Business
Table 48. AbbVie Inc Recent Developments
Table 49. KD Pharma Group Company Information, Head Office, Market Area, and Industry Position
Table 50. KD Pharma Group Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 51. KD Pharma Group Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. KD Pharma Group Company Profile and Main Business
Table 53. KD Pharma Group Recent Developments
Table 54. BASF SE Company Information, Head Office, Market Area, and Industry Position
Table 55. BASF SE Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 56. BASF SE Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. BASF SE Company Profile and Main Business
Table 58. BASF SE Recent Developments
Table 59. Corbion Company Information, Head Office, Market Area, and Industry Position
Table 60. Corbion Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 61. Corbion Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Corbion Company Profile and Main Business
Table 63. Corbion Recent Developments
Table 64. DSM Company Information, Head Office, Market Area, and Industry Position
Table 65. DSM Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 66. DSM Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. DSM Company Profile and Main Business
Table 68. DSM Recent Developments
Table 69. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 70. AstraZeneca Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 71. AstraZeneca Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. AstraZeneca Company Profile and Main Business
Table 73. AstraZeneca Recent Developments
Table 74. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 75. GSK plc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 76. GSK plc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. GSK plc Company Profile and Main Business
Table 78. GSK plc Recent Developments
Table 79. Fresenius Kabi AG Company Information, Head Office, Market Area, and Industry Position
Table 80. Fresenius Kabi AG Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 81. Fresenius Kabi AG Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Fresenius Kabi AG Company Profile and Main Business
Table 83. Fresenius Kabi AG Recent Developments
Table 84. Croda International Plc Company Information, Head Office, Market Area, and Industry Position
Table 85. Croda International Plc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 86. Croda International Plc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Croda International Plc Company Profile and Main Business
Table 88. Croda International Plc Recent Developments
Table 89. AMARIN CORPORATION Company Information, Head Office, Market Area, and Industry Position
Table 90. AMARIN CORPORATION Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 91. AMARIN CORPORATION Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. AMARIN CORPORATION Company Profile and Main Business
Table 93. AMARIN CORPORATION Recent Developments
Table 94. ANI Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
Table 95. ANI Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 96. ANI Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. ANI Pharmaceuticals, Inc Company Profile and Main Business
Table 98. ANI Pharmaceuticals, Inc Recent Developments
Table 99. Epax Company Information, Head Office, Market Area, and Industry Position
Table 100. Epax Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 101. Epax Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Epax Company Profile and Main Business
Table 103. Epax Recent Developments
Table 104. Strides Pharma Science Limited Company Information, Head Office, Market Area, and Industry Position
Table 105. Strides Pharma Science Limited Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 106. Strides Pharma Science Limited Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Strides Pharma Science Limited Company Profile and Main Business
Table 108. Strides Pharma Science Limited Recent Developments
Table 109. Pharma Marine AS Company Information, Head Office, Market Area, and Industry Position
Table 110. Pharma Marine AS Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 111. Pharma Marine AS Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Pharma Marine AS Company Profile and Main Business
Table 113. Pharma Marine AS Recent Developments
Table 114. KinOmega Biopharm Inc Company Information, Head Office, Market Area, and Industry Position
Table 115. KinOmega Biopharm Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 116. KinOmega Biopharm Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. KinOmega Biopharm Inc Company Profile and Main Business
Table 118. KinOmega Biopharm Inc Recent Developments
Table 119. Camber Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
Table 120. Camber Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Models, Specifications, and Application
Table 121. Camber Pharmaceuticals, Inc Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Camber Pharmaceuticals, Inc Company Profile and Main Business
Table 123. Camber Pharmaceuticals, Inc Recent Developments
List of Figures
Figure 1. Omega-3 Ingredients for Pharmaceuticals Picture
Figure 2. Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Omega-3 Ingredients for Pharmaceuticals Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Omega-3 Ingredients for Pharmaceuticals Sales Quantity (K Units) & (2018-2029)
Figure 7. China Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Omega-3 Ingredients for Pharmaceuticals Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Omega-3 Ingredients for Pharmaceuticals Market Share of Global, 2018-2029
Figure 10. Global Omega-3 Ingredients for Pharmaceuticals Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Omega-3 Ingredients for Pharmaceuticals Key Participants, Market Share, 2022
Figure 12. Global Omega-3 Ingredients for Pharmaceuticals Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Omega-3 Ingredients for Pharmaceuticals Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Omega-3 Ingredients for Pharmaceuticals Production Market Share & Forecast by Region, 2018-2029
Figure 15. Omega-3 Ingredients for Pharmaceuticals Industry Chain
Figure 16. Omega-3 Ingredients for Pharmaceuticals Procurement Model
Figure 17. Omega-3 Ingredients for Pharmaceuticals Sales Model
Figure 18. Omega-3 Ingredients for Pharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 19. Docosahexaenoic Acid
Figure 20. Eicosapentaenoic Acid
Figure 21. Alpha-Linolenic Acid
Figure 22. By Type, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 25. By Type, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Cardiovascular Diseases
Figure 28. Autoimmune Diseases
Figure 29. Bone & Joint Disorders
Figure 30. Neurological Disorders
Figure 31. Other
Figure 32. By Application, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Omega-3 Ingredients for Pharmaceuticals Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2018-2029
Figure 39. North America Omega-3 Ingredients for Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2022
Figure 41. Europe Omega-3 Ingredients for Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2022
Figure 43. Asia Pacific Omega-3 Ingredients for Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2022
Figure 45. South America Omega-3 Ingredients for Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Omega-3 Ingredients for Pharmaceuticals Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa Omega-3 Ingredients for Pharmaceuticals Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets